Featured Research

from universities, journals, and other organizations

Injectable and oral birth control do not adversely affect glucose and insulin levels, study shows

Date:
December 21, 2010
Source:
University of Texas Medical Branch at Galveston
Summary:
Fasting glucose and insulin levels remain within normal range for women using injectable or oral contraception, with only slight increases among women using depot medroxyprogesterone acetate (DMPA), commonly known as the birth control shot, according to new research.

Fasting glucose and insulin levels remain within normal range for women using injectable or oral contraception, with only slight increases among women using depot medroxyprogesterone acetate (DMPA), commonly known as the birth control shot, according to new research from the University of Texas Medical Branch (UTMB Health) in Galveston.

Related Articles


The study, published in the January 2011 issue of Obstetrics and Gynecology and conducted over three years, is the largest to measure fasting glucose and insulin levels among women using DMPA, oral (desogestrel) contraception and non-hormonal (bilateral tubal ligation, condom or abstinence) methods. Researchers found that DMPA users' glucose levels increased steadily during the first 30 months of use, with the greatest increase occurring during the first six months. The observed increases, which were less than those reported in previous studies, were not significant enough to cause concern.

There are 62 million women of reproductive age in the United States. More than two million American women use DMPA, including approximately 400,000 teens, and more than 11 million use oral contraception.

"Previous studies were limited in scope and offered conflicting results, which led physicians to question whether hormonal contraception could lead to diabetes," says lead author Dr. Abbey Berenson, professor, Department of Obstetrics and Gynecology and director of the Center for Interdisciplinary Research in Women's Health. "Further studies are needed to determine how women with diabetes are affected by DMPA and oral contraception, but these results are reassuring for non-diabetic women already receiving the shot or on the pill."

A Body of Research on the Effects of Contraception

The findings are the fourth in a series of UTMB Health studies published in Obstetrics and Gynecology that add to the growing literature enabling physicians to better counsel women accurately about the positive and adverse side effects associated with widely used forms of contraception.

Other studies included in the series examined the effect of contraception on weight gain and bone density loss. All of the studies followed a sample of 703 African-American, Hispanic and white women between the ages of 16 -33 years-old from 2001 through 2004 who chose their own contraception method. Researchers also examined such variables as: race and ethnicity, age, parity, duration of use, previous use of contraceptive method, lifestyle behaviors like diet, smoking, drinking and physical exercise, and socioeconomic status.

Findings include:

Contraception and Bone Loss

In a study published in January 2010, Berenson and UTMB Health co-author Dr. Mahbubur Rahman, assistant professor, Department of Obstetrics and Gynecology and Center for Interdisciplinary Research in Women's Health, examined the relationship between contraception and bone mineral density (BMD) loss. They found:

  • Nearly half of women using DMPA experienced high BMD loss in the hip or lower spine within two years of beginning the contraceptive.
  • Women using DMPA who smoke, have low levels of calcium intake and never gave birth were at the highest risk for BMD loss.
  • High-risk women continued to experience significant loss in BMD during the third year of DMPA use, especially in the hip -- the most common fracture site in elderly women.
  • Age, race or ethnicity, previous contraceptive use and body mass index (BMI) were not associated with higher BMD loss.

Contraception and Weight Gain

In two separate studies on weight gain and contraception use, published in March and August 2009, Berenson and Rahman found:

Women using DMPA gained an average of 11 pounds and increased their body fat by 3.4 percent over three years.

  • Women who switched from DMPA to non-hormonal contraception began to slowly lose the weight and fat mass they gained -- nearly four pounds over two years, while those who used oral contraception after the shots gained an average of four additional pounds in the same time span. The amount of weight gained was dependent on length of time DMPA was used, as the rate of weight gain slowed over time.
  • Twenty-five percent of DMPA users whose weight increased by five percent within the first six months of use, called "early gainers," were at risk for continued, excessive weight gain. The remaining 75 percent ("regular gainers") gained only a small amount of weight or did not observe any change in their weight.
  • Early gainers -- who went on to gain an average of 24 pounds over three years -- exhibited three major risk factors: a body mass index under 30; having children before starting DMPA; and a self-reported increase in appetite after six months of DMPA use.
  • On average, early gainers increased their body weight an average of 19 pounds more than the regular gainers, who saw an average increase of five and a half pounds over three years.

A More Informed Physician-Patient Relationship

"Taken together, this body of research helps dispel myths surrounding birth control and shed light on side effects that had been anecdotally reported but not yet proven," says Berenson. "Physicians can now better explain the risks and benefits of various birth control methods and take appropriate action to protect patients' long-term health, which may include switching to another contraception method."

All research was supported by the National Institute of Child Health & Human Development. Yen-Chi L. Le, PhD, Department of Obstetrics and Gynecology also contributed to the studies.


Story Source:

The above story is based on materials provided by University of Texas Medical Branch at Galveston. Note: Materials may be edited for content and length.


Cite This Page:

University of Texas Medical Branch at Galveston. "Injectable and oral birth control do not adversely affect glucose and insulin levels, study shows." ScienceDaily. ScienceDaily, 21 December 2010. <www.sciencedaily.com/releases/2010/12/101220200002.htm>.
University of Texas Medical Branch at Galveston. (2010, December 21). Injectable and oral birth control do not adversely affect glucose and insulin levels, study shows. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2010/12/101220200002.htm
University of Texas Medical Branch at Galveston. "Injectable and oral birth control do not adversely affect glucose and insulin levels, study shows." ScienceDaily. www.sciencedaily.com/releases/2010/12/101220200002.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) — The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins